2023-02-25Rezension
Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis
Dahms, Karolina; Mikolajewska, Agata; Ansems, Kelly; Metzendorf, Maria-Inti; Benstoem, Carina; Stegemann, Miriam
Background
At the end of 2021, the European Medicines Agency (EMA) expanded its approval for the recombinant
human interleukin‑1 (IL‑1) receptor antagonist Anakinra for the treatment of COVID‑19 patients with elevated ...
